Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster
Status:
Suspended
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and tolerability of three different doses of Pascorbin® besides
standard medication with placebo and the reduction of herpes zoster-associated clinical
symptoms as an add-on therapy for patients suffering from acute herpes zoster in primary care